Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Authors :: Tomasz Sacha
Spencer Hermanson
Helen Vålerhaugen
Israel Bendit
Smadar Avigad
Carmen Chillón
Shalini C. Reshmi
Gareth Gerrard
Sandra Markovic
Martin C. Mueller
Gianni Cazzaniga
Hubert Serve
J. J. M. Van Dongen
Katarzyna Borg
Tomáš Jurček
Christa Homburg
Oliver G. Ottmann
Veli Kairisto
Fabrizio Pane
Jean-Michel Cayuela
T Touloumenidou
Beat W. Schäfer
Thoralf Lange
Heike Pfeifer
Loredana Elia
Eva Herrmann
Thomas Lion
Christine Damm-Welk
Susanna Akiki
Sandrine Hayette
Orietta Spinelli
Hélène Cavé
Giovanni Martinelli
Peter Vandenberghe
Susanne Schnittger
A. Juh
Lena Rai
Jan Zuna
Vincent H.J. van der Velden
Source :: Leukemia. 34:1970-1970
Publication Year :: 2020
Publisher :: Springer Science and Business Media LLC, 2020.

Subjects :: Cancer Research
business.industry
Lymphoblastic Leukemia
Philadelphia positive
Quantitative Reverse Transcriptase PCR
Hematology
medicine.disease
Minimal residual disease
Leukemia
Bcr abl1
Oncology
medicine
Cancer research
business

Full Text Access

Tools